Stockwinners Market Radar for March 09, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:43 EST Williams-Sonoma CEO sells $3.04M in common stock - In a regulatory filing, Williams-Sonoma disclosed that its CEO Laura Alber sold 20K shares of common stock March 7th in a total transaction size of $3.04M.

18:41 EST Kewaunee Scientific's Indian unit awarded $17.3M contract by Dangote Oil - Kewaunee Scientific Corporation announced that the company's Indian subsidiary has been awarded a $17.3M contract for laboratory furniture and equipment, by the Dangote Oil Refinery Company Limited, located in Lagos, Nigeria. The Dangote Oil Refinery is a 650,000 barrels per day integrated refinery project under construction in the Lekki Free Zone near Lagos, Nigeria. It is expected to be Africa's largest oil refinery and the world's largest single-train facility when completed. The refinery is intended to meet 100% of the Nigerian requirement for all refined products and have a surplus for export. Dangote Petroleum Refinery is a multi-billion-dollar project that Dangote Oil believes will create a market for $11B per year of Nigerian crude oil.

17:50 EST Veritex director Arcilia Acosta acquires 26,316 common shares - In a regulatory filing, Veritex Holdings director Arcilia Acosta disclosed the purchase of 26,316 common shares of the company on March 8 at a price of $38 per share.

17:44 EST Patterson-UTI CFO Charles sells $1.2M in company shares - Patterson-UTI CFO Andrew Charles disclosed in a filing that he had sold 75,000 shares of company stock at $15.95 per share on March 7, for a total transaction amount of $1,196,250.

17:32 EST Granite awarded $32M highway realignment in California - Granite has been selected for the State Route 20 Omega Curve Realignment project in Nevada County, California. The project is awarded by Caltrans and funded by State and Federal aid. The $32M contract is anticipated to be included in Granite's Q1 CAP. This project realigns two existing curves along State Route 20, a high-traffic area with many accidents, and will create a safer passage for the traveling public in Nevada County. Originally second in the bid rankings, Granite was awarded this project because of its clearly articulated Disadvantaged Business Enterprise strategy and commitment. Materials for this project will be supplied by Granite's Bradshaw Hot Plant facility-42,000 tons of Hot Mix Asphalt will be used for paving the new alignment. The project is expected to start in April 2022 and anticipated to be complete in summer 2023.

17:13 EST CI&T sees Q1 net revenue up at least 64% from 1Q21 to R$485.0M

17:05 EST Franco-Nevada sees 2022 production "slightly lower" than 2021 - Franco-Nevada anticipates a slightly lower production profile in 2022 in comparison to 2021, with attributable GEOs expected to range between 680,000 and 740,000 GEOs. Of this, Precious Metal assets are expected to contribute between 510,000 and 550,000 GEOs. Estimates depletion expense to be $270M-$300M. Remaining capital commitment to the Royalty Acquisition Venture with Continental is $91.6M.

16:58 EST Transocean COO sells $1.75M in common stock - In a regulatory filing, Transocean disclosed that its COO Keelan Adamson sold 349K shares of common stock on March 7th in a total transaction size of $1.75M.

16:49 EST Oil-Dri announces price increases for sports field products - Oil-Dri Corporation of America announced that it will implement price increases for its sports field products, effective April 1, 2022. Pricing actions are necessary as the company continues to face significant inflation across many key cost inputs, including packaging, materials, natural gas, and non-fuel manufacturing costs. "In order to continue our commitment to delivering high quality products to our customers, we must raise prices to relieve some of the pressure caused by current inflationary headwinds," said Daniel S. Jaffee, President and Chief Executive Officer. "These price adjustments will contribute to the Company's efforts to rebuild margins to historical levels."

16:47 EST Trustco Bank announces buysback of up to 200K shares - TrustCo Bank "announced that its Board of Directors has approved a stock repurchase program. Under the stock repurchase program, TrustCo may repurchase up to 200,000 shares of its common stock, or approximately 1% of its current outstanding shares."

16:42 EST Amazon board authorizes repurchase of up to $10B of common stock - According to a regulatory filing, on March 9, 2022, the Board of Directors of Amazon authorized the company to repurchase up to $10B of the company's common stock. The program allows the company to repurchase its shares opportunistically from time to time when it believes that doing so would enhance long-term shareholder value. The repurchase authorization does not have a fixed expiration. Purchases may be effected through one or more open market transactions, privately negotiated transactions, transactions structured through investment banking institutions, or a combination of the foregoing. This stock repurchase authorization replaces the previous $5B stock repurchase authorization, approved by the Board of Directors in 2016, under which the company had repurchased $2.12B of its shares.

16:39 EST Artisan Partners reports February AUM of $159.8B - Artisan Partners reported that its preliminary assets under management, or AUM, as of February 28 totaled $159.8B. Artisan Funds and Artisan Global Funds accounted for $77.5B of total firm AUM, while separate accounts and other AUM accounted for $82.3B.

16:37 EST GeoPark targets 2022 production increase of 5%-10% - The company "targets 2022 production increase of 5-10% to 35,500-37,500 boepd, which does not include production from Argentina and Brazil and any potential production from 15-20 exploration wells being drilled."

16:33 EST GeoPark doubles quarterly dividend to 8.2c per share from 4.1c - The dividend is payable on March 31, 2022 to the shareholders of record at the close of business on March 24, 2022.

16:32 EST Allegheny Technologies terminates joint venture with Russian-based VSMPO - ATI has termination of Uniti, LLC, its joint venture with Russian-based VSMPO-AVISMA - Verkhnaya Salda Metallurgical Production Association - Berezniki Titanium-Magnesium Works - to market and sell a range of commercially pure titanium products. The joint venture primarily focused on selling to industrial markets such as power generation, chemical and petroleum processing, automotive, and transportation. It does not serve the aerospace, defense or medical markets. The joint venture is expected to wind up no later than year-end 2022.

16:31 EST EnerSys announces new $150M stock repurchase authorization - EnerSys announced that its Board of Directors has established a new $150M stock repurchase authorization with no expiration date. This new authorization brings the Company's total outstanding repurchase authorization to an aggregate of $181M including $31M available under the Board's previous repurchase authorization approved on November 4, 2021. In fiscal year 2022 to date, the Company has repurchased $159M in shares.

16:29 EST MaxCyte appoints Cenk Sumen as chief scientific officer - MaxCyte announced Cenk Sumen as chief scientific officer, or CSO. With a track record of scientific, technological and business development expertise, Sumen brings experience in technology, application and platform assessments, the development of commercial partnerships and interdepartmental collaboration to accelerate scientific and technical direction. Sumen comes to MaxCyte from Stemson Therapeutics, where he was the CTO and led all aspects of technology, scale-up, process development and automation.

16:26 EST Trean names CEO O'Brien as Executive Chairman, appoints COO Baron as CEO - Trean Insurance announced that its Board of Directors has appointed current CEO Andrew O'Brien as Executive Chairman of the Board and appointed current President and Chief Operating Officer Julie Baron as CEO, both effective July 1. Ms. Baron will also join the Board of Directors of Trean effective July 1.

16:20 EST Trean sees Q1 loss ratio to be between 61.5%-62.5% of net earned premium - "As noted in management commentary, the Company expects first quarter 2022 loss ratio to be between 61.5% and 62.5% of net earned premium," said the company in a statement.

16:20 EST 3D Systems CEO Graves sells 40,837 common shares - In a regulatory filing, 3D Systems president and CEO Jeffrey Graves disclosed the sale of 40,837 common shares of the company on March 9 at a price of $14.7596 per share.

16:16 EST Invesco reports preliminary AUM $1.53T as of February 28 - A decrease of 1.3% versus previous month-end. The firm achieved net long-term inflows of $3.4B this month. Money market net inflows were $3.6B.

16:13 EST Allison Transmission collaborates with FCCC on walk-in van program - Allison Transmission announced that uprate variants of the Allison 1000 Series and 2000 Series transmissions will be integrated into Freightliner Custom Chassis Corporation's new powertrain combination for its MT walk-in van chassis. The transmissions will be equipped with Allison's next-generation electronic controls platform. Built on decades of evolution and experience and combined with state-of-the-art microprocessor and software operating system technology, the platform is capable of delivering advanced communications, functional safety, cybersecurity and over-the-air programming. "Allison has long shared in our commitment to innovation and excellence, which is why we're excited to once again partner with them on these latest updates to our walk-in van product lineup," said Greg Baker, Commercial Product Manager for FCCC. "These new Allison transmissions will provide a number of important enhancements and features to the next generation of our MT chassis."

16:08 EST Virtus Investment reports preliminary total AUM $183.7B as of February 28 - In addition, the company provided services to $3.5B of other fee-earning assets, which are not included in assets under management.

16:07 EST Intellia Therapeutics gets FDA orphan drug designation for NTLA-5001 for AML - Intellia Therapeutics announced that the U.S. Food and Drug Administration has granted orphan drug designation for Intellia's ex vivo investigational T cell receptor,TCR, -T cell therapy, NTLA-5001, for the treatment of acute myeloid leukemia, AML. NTLA-5001 is an autologous TCR-T cell therapy designed to target the Wilms' Tumor antigen, which is highly expressed in AML and many other hematologic and solid tumors. NTLA-5001 is currently being evaluated in a Phase 1/2a study in adults with persistent or recurrent AML who have previously received first-line therapy. "The FDA's decision to grant orphan drug designation for NTLA-5001 reflects the serious need for novel treatment options for people living with AML, a disease with notably poor long-term survival," said Intellia President and Chief Executive Officer John Leonard, M.D. "As part of our full-spectrum genome editing strategy, we seek to leverage our proprietary CRISPR/Cas9-based platform to engineer differentiated cell therapies targeting cancers for which there are currently limited or no treatment options. We look forward to advancing our investigational TCR-T cell therapy, NTLA-5001, through the clinic in hopes of improving future treatment options for patients in need." The FDA's Orphan Drug Designation program provides orphan status to drugs defined as those intended for the treatment, diagnosis or prevention of rare diseases that affect fewer than 200,000 people in the United States. Orphan drug designation qualifies the sponsor of the drug for certain development incentives, including tax credits for qualified clinical testing, prescription drug user-fee exemptions and seven-year marketing exclusivity upon FDA approval

16:04 EST ViewRay enters into cooperation agreement with Hudson Executive Capital - ViewRay has reached an agreement with Hudson Executive Capital to appoint Susan Schnabel to the ViewRay Board of Directors as an independent director, effective as of March 8. In addition, ViewRay has retained Sai Nanduri, a Senior Investment Analyst and representative of HEC, as a consultant to work with the company to enhance shareholder returns. The company has agreed to consider Nanduri as a candidate for election to the Board at the 2023 annual stockholder meeting. ViewRay has entered into a cooperation agreement with HEC, which currently owns approximately 8.8% of the company's outstanding common stock, pursuant to which HEC has agreed to customary standstill and voting commitments, among other provisions. Kevin Xie has tendered his resignation from the ViewRay Board effective March 8. The board will continue to consist of 9 members, eight of whom are independent. Susan Schnabel is a founder and has served as the Co-Managing Partner of aPriori Capital Partners since 2014. Prior to forming aPriori Capital, Schnabel worked at Credit Suisse from 2000 to 2014 where she served as Managing Director in the Asset Management Division and Co-Head of DLJ Merchant Banking.

15:44 EST Lion Electric announces partnerships with truck upfitters - The Lion Electric Company announced what it called "several key partnerships" with truck upfitters to provide new fully electrified refrigerated, dry freight and aluminum stake body options for its Lion6 zero-emission urban truck. The new partnerships include equipment upfit options from Morgan Truck Body, Thermo King, Knapheide and CM Truck Beds, the company stated in a press release. "The wide variety of upfit components we are debuting at this year's Work Truck Week is proof that electrification has arrived for a broad range of truck fleet customers, from dry cargo fleets to those with temperature-sensitive requirements. We are pleased to be working in close collaboration with four industry leaders as we continue to move toward a zero-emission future in trucking, and look forward to continuing to introduce new applications to our highly flexible class 5 to class 8 chassis vehicles," said Brian Piern, Chief Commercial Officer of Lion Electric.

15:26 EST Wabtec, BNSF Railway partner on new biofuel project - Wabtec and BNSF Railway are partnering to advance sustainability in the rail industry with a new biofuel project aimed at quantifying the impact of alternative fuels on emissions, durability, and performance in Wabtec locomotives. BNSF and Wabtec will begin testing biofuel in the second quarter of this year. The two companies will demonstrate the performance of biodiesel and renewable diesel in revenue service on Wabtec Tier 3 and Tier 4 Evolution Series locomotives in California. BNSF will operate the locomotives between Barstow and Los Angeles, California.

14:45 EST Deere suspends shipments of machines to Russia - Deere has suspended shipments to Russia and Belarus. "John Deere is deeply saddened by the significant escalation of events in Ukraine. The safety, welfare, and well-being of our employees in the region remains our top priority, and we continue to support and maintain close communication with our affected teams, providing necessary resources when possible. Our thoughts are with our employees, their families as well as our dealers, customers and all those impacted by this crisis. Two weeks ago, we suspended shipments of machines to Russia and then subsequently, Belarus. We continue to monitor the situation closely while we fully abide by U.S. and international sanctions. The John Deere Foundation has additionally been working directly with a number of organizations, including multiple UN agencies, to mobilize resources to support Ukrainians impacted by the crisis. Our mission is, and always has been, to help our customers feed the world," the company said.

14:26 EST Disney expects to reinstate dividend when 'able to reinstate A debt rating' - Answering a shareholder question on reinstating stock dividend at the company's Annual Meeting of Shareholders, CEO Bob Chapek said Disney is investing in growth, but anticipates reinstating its dividend when able to reinstate A debt rating.

14:02 EST 'Obi-Wan Kenobi' trailer presented at Disney Annual Meeting of Shareholders - The new Star Wars series "Obi-Wan Kenobi" is set to premiere on Disney+ on May 25. "Obi-Wan Kenobi" will pick up with its eponymous hero ten years after the events of "Star Wars: Revenge of the Sith." Disney says Disney+ and Disney+ Hotstar is now available in over 60 countries.

13:49 EST North American rail traffic fell 3.3% in week ended March 5 - The Association of American Railroads, AAR, reported U.S. rail traffic for the week ending March 5. For this week, total U.S. weekly rail traffic was 505,177 carloads and intermodal units, down 1.9% compared with the same week last year. Total carloads for the week ending March 5 were 238,870 carloads, up 2.8% compared with the same week in 2021, while U.S. weekly intermodal volume was 266,307 containers and trailers, down 5.8% compared to 2021. North American rail volume for the week ending March 5 on 12 reporting U.S., Canadian and Mexican railroads totaled 335,676 carloads, up 0.5% compared with the same week last year, and 348,821 intermodal units, down 6.7% compared with last year. Total combined weekly rail traffic in North America was 684,497 carloads and intermodal units, down 3.3%. North American rail volume for the first nine weeks of 2022 was 5,894,649 carloads and intermodal units, down 3.9% compared with 2021. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific (CP), Kansas City Southern (KSU), Norfolk Southern (NSC), Union Pacific (UNP), Greenbrier (GBX),Trinity Industries (TRN), FreightCar America (RAIL) and Wabtec (WAB). Reference Link

13:33 EST Virgin Orbit to launch first satellite developed in Wales this summer - Virgin Orbit and European in-space manufacturing tech start-up Space Forge announced earlier an agreement to launch the first satellite developed in Wales in summer 2022. The satellite will be launched as part of a broader joint UK-US mission to open the country's first domestic space port in summer 2022 out of Spaceport Cornwall in Newquay, Cornwall. "We at Virgin Orbit are delighted to have been chosen to move Space Forge forward in their space journey as we look forward to our inaugural Cornwall launch. Space Forge is joining the growing community of space innovators advancing space technologies for the betterment of our world," said Virgin Orbit CEO Dan Hart. Shares of Virgin Orbit are up over 17% in afternoon trading.

13:21 EST Airbus, Spirit AeroSystems partner for wings of CityAirbus NextGen - Airbus (EADSY) has signed an agreement with Spirit AeroSystems (SPR) through its subsidiary for the development of CityAirbus NextGen's wings. This partnership will support Airbus' exploration of disruptive aircraft design while complying with the most stringent regulations. Spirit AeroSystems will be responsible for developing and manufacturing CityAirbus NextGen's wings in Belfast, Northern Ireland. Both partners' ambition is to achieve a minimum weight solution while ensuring the highest levels of safety. The structural concept of the eVTOL's fixed wings will be able to transmit the related aerodynamic loads while being optimized for the right balance between hover and cruise efficiency. CityAirbus NextGen's distributed propulsion system will contribute to reducing the influence of air turbulence. Reference Link

12:58 EST Cano Health surges after Third Point urges company to consider sale - Shares of Cano Health (CANO) are sharply higher after Daniel Loeb's Third Point reported a 6.37% stake in the company in a regulatory filing earlier this morning and said the firm believes the company "should immediately engage financial and legal advisors to commence a review of strategic alternatives." The filing stated that Third Point has "confidence in the [company's] operating strategy and management team. However given recent developments at the [company] and taking into account the market's largely unfavorable view of companies taken public through special purpose acquisition vehicles, the [firm] believes the Board of Directors should immediately engage financial and legal advisors to commence a review of strategic alternatives. The [firm believes] this strategic review should focus on a sale of the [company], and that a properly run sales process is likely to result in offers representing a substantial premium to the [company's] trading price. The [firm believes] that the [company] is unlikely to achieve such valuation on a stand-alone basis, in part due to structural issues with its shareholder base. The [firm has] no present plan to pursue a proxy contest with the [company], but may consider initiating a proxy contest seeking to elect one or more members of the Board and bring such other proposals as the [firm deems] appropriate should the Board not adequately address the value gap between the current share price of the [company] and the intrinsic value thereof, including by commencing a review of strategic alternatives," the filing stated. In afternoon trading, Cano Health shares have jumped $1.66, or 36%, to $6.22.

12:52 EST Honeywell suspends substantially all business in Russia, Belarus - Honeywell released a statement yesterday about its business in Russia and Belarus: "Given the current conditions in eastern Europe, we have suspended substantially all of our sales, distribution and service activities in Russia and Belarus. We continue to evaluate the situation. Our number one priority continues to be the safety and security of our employees and partners in the region and responding to their immediate needs. Our collective thoughts are with the millions of refugees and we hope to see a peaceful resolution quickly." Reference Link

12:34 EST Deutsche Bank reports net loan exposure to Russia EUR 600M

12:15 EST Natera halted for volatility after dropping 49% to $28.05

12:07 EST RBC signs second long-term renewable enerfy Power Purchase Agreement - RBC announced the signing of its second long-term, renewable energy Power Purchase Agreement. The power purchased directly contributes to two key targets of the RBC Climate Blueprint - to reduce emissions by 70% and to source 100% of its electricity from renewable and non-emitting sources, both by 2025. The agreement was signed with Berkshire Hathaway Energy Canada to directly support the development of their new 130 MW Rattlesnake Ridge Wind Power Project in Medicine Hat, Alberta, Canada anticipated to complete construction and begin producing renewable power by May 2022. The construction of the project's 26 wind turbines is expected to employ 150 construction workers at peak development. Once operational, the project is expected to inject $56 million of capital investment into the local Alberta economy and produce enough energy to power 78,000 local homes annually.

12:00 EST Nine Energy Service falls -16.6% - Nine Energy Service is down -16.6%, or -94c to $4.72.

12:00 EST DB Gold Double Long falls -24.1% - DB Gold Double Long is down -24.1%, or -$14.84 to $46.66.

12:00 EST Figs rises 29.3% - Figs is up 29.3%, or $4.11 to $18.15.

11:57 EST Applied DNA Sciences Linea 2.0 COVID-19 Assay approved for emergency use - The Linea 2.0 COVID-19 Assay has been granted Emergency Use Authorization by the FDA, according to a notice posted by the agency. The Linea 2.0 COVID-19 Assay will be performed at Applied DNA Clinical Labs. The Linea 2.0 COVID-19 Assay is intended for use by qualified and trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures. The Linea 2.0 COVID-19 Assay is only for use under the Food and Drug Administration's Emergency Use Authorization, the notice states. Reference Link

11:43 EST Warner Bros. game 'Gotham Knights' out October 25, 2022 - Warner Bros. (T) said that its upcoming video game "Gotham Knights," which is set in the Batman universe, will release on October 25, 2022. The game is set to come out for PC, PlayStation 4 (SONY), PS5, Xbox One (MSFT), and Xbox Series X/S. Reference Link

11:16 EST Brown-Forman suspends commercial operations in Russia - Brown-Forman said in a statement posted to its corporate website: "We watch in horror as millions of Ukrainians continue to face the somber realities of war. Our thoughts are with them and all those who are full of fear and uncertainty, displaced and desiring refuge, suffering and seeking peace, or mourning and missing loved ones. We are staying in close contact with our Ukrainian colleagues, providing assistance and financial support to help them during this time of need. In addition, we are making donations to UNICEF, UNHCR, and International Medical Corps, organizations aiding Ukrainian children and all refugees and offering medical assistance. In light of the war in Ukraine, we are suspending commercial operations in Russia. We join the global community in calling for peace." Reference Link

10:42 EST Fujifilm Sonosite files patent infringement lawsuit against Butterfly Network - FUJIFILM Sonosite (FUJIY) announced it has filed a patent infringement lawsuit against Butterfly Network (BFLY) in the United States District Court for the District of Delaware. FUJIFILM has asserted seven patents (U.S. Patent Nos. 7,169,108; 7,867,168; 8,128,050; 8,861,822; 9,538,985; 6,901,157; and 8,360,981) pertaining to fundamental technologies for acquiring ultrasound images at the point of care with portable handheld systems. The patents cover various aspects of point of care ultrasound solutions, including the use of a probe coupled to a mobile device, elements of the graphical interface, as well as aspects related to the processing and display of ultrasound images. FUJIFILM Sonosite is seeking remedies including damages related to Butterfly Network's infringement through its unauthorized use, manufacture, marketing, promotion and sale of Butterfly Network's IQ/IQ+ POCUS products.

10:23 EST Marine Petroleum Trust trading halted, volatility trading pause

10:16 EST Ecoark's Banner Midstream completes the drilling of Louisiana oil well - Ecoark announced last night that its wholly owned subsidiary, Banner Midstream has successfully completed the drilling of an oil project on its 9,615 acre oil and gas mineral lease, OGML, in the Blackhawk oil field in Concordia Parish, Louisiana on March 4, 2022. Banner's wholly-owned subsidiary, White River Operating, led the drilling effort in partnership with a local energy services provider. The completed well was logged March 5, 2022. White River expects to perforate, complete, and bring the oil well to production in the coming weeks. "We are pleased to announce this successful oil project," stated Randy May, Chairman and CEO of Ecoark. "We began planning and permitting this project during a period of significant lower oil prices and are proud to be in a position to turn on production at a critical time for the country's domestic energy supply. We have several new drilling projects as well as re-entry projects to access oil behind pipe that we plan to execute in the coming months," added May. "These projects are considered lower risk and higher reward, so we can mitigate dry hole risk across a series of multiple projects. We look forward to keeping our investors informed on future developments across our energy subsidiaries."

10:00 EST DB Gold Double Long falls -24.6% - DB Gold Double Long is down -24.6%, or -$15.14 to $46.35.

10:00 EST Nine Energy Service falls -25.7% - Nine Energy Service is down -25.7%, or -$1.46 to $4.21.

10:00 EST Figs rises 27.4% - Figs is up 27.4%, or $3.85 to $17.89.

09:58 EST Research Solutions partners with scite for Smart Citations - Research Solutions has partnered with scite. With this partnership, Research Solutions will now display Smart Citations from scite in their tools, specifically in Bibliogo and Article Galaxy alongside displayed article results. Smart Citations allow users to quickly see how an article has been cited by providing the citation context and identifying supporting or contrasting articles. This partnership will make it as efficient as possible for Research Solutions customers to quickly identify articles supporting or contrasting an article they need to license.

09:54 EST Finch Therapeutics Group Inc trading resumes

09:47 EST Genenta Science SpA(ADR) trading halted, volatility trading pause

09:47 EST Yext falls -25.7% - Yext is down -25.7%, or -$1.52 to $4.40.

09:47 EST XPO Logistics rises 15.0% - XPO Logistics is up 15.0%, or $9.28 to $71.20.

09:47 EST Cano Health rises 23.2% - Cano Health is up 23.2%, or $1.06 to $5.62.

09:46 EST Indonesia Energy Corporation Limited trading resumes

09:45 EST Diversey Holdings trading resumes

09:42 EST Judiciary Committee refers Amazon to DOJ for execs' 'potential criminal conduct' - Bipartisan Members of the House Judiciary Committee sent a letter to Attorney General Merrick Garland to alert the Department of Justice to potentially criminal conduct by Amazon and its senior executives, the Committee announced. The letter explains how Amazon has engaged in a "pattern and practice" of misleading conduct that appeared designed to "influence, obstruct, or impede" the Committee's 16-month investigation into competition in digital markets. House Judiciary Committee Chair Jerrold Nadler, Antitrust Subcommittee Chair David N. Cicilline, Antitrust Subcommittee Ranking Member Ken Buck, Antitrust Subcommittee Vice Chair Pramila Jayapal, and Representative Matt Gaetz issued the following joint statement on their letter: "Last Congress, the Judiciary Committee conducted an extensive, bipartisan investigation into competition in digital markets. Throughout the investigation and in follow-up inquiries, senior executives at Amazon engaged in a pattern and practice of misleading behavior before the Committee. The Committee extended multiple opportunities for Amazon to clarify these misconceptions, yet executives continued to thwart our efforts to uncover the truth about their business practices. Amazon and its executives must be held accountable for this behavior. That is why we are referring this matter to the Department of Justice to investigate whether Amazon obstructed Congress or violated other federal laws. We look forward to hearing from the Department on this important matter." Reference Link

09:40 EST Anika Therapeutics trading resumes

09:38 EST TerrAscend to close Gage Growth acquisition on March 10 - TerrAscend Corp. (TRSSF) and Gage Growth Corp. (GAEGF) announced that they intend to close the previously announced acquisition of Gage by TerrAscend by way of a court-approved plan of arrangement under the Canada Business Corporations Act on March 10, 2022, subject to satisfaction or waiver of all remaining closing conditions. Upon completion of the Transaction, TerrAscend will have an expanded footprint with owned and managed operations in California, Michigan, Maryland, New Jersey, Pennsylvania, and Canada, including 7 cultivation and processing facilities and 25 operating dispensaries serving medical and adult-use cannabis markets in the U.S. and Canada. It is expected that the Gage shares will be halted after closing and the Canadian Securities Exchange will delist the Gage shares upon completion of the Transaction. In order to facilitate the closing of the Transaction for the benefit of both TerrAscend and Gage, the parties have agreed to certain amendments to the arrangement agreement governing the Transaction, and the membership interest purchase agreement entered into with the owner of the licenses that Gage supports in the State of Michigan. The Amendments will permit the Transaction to close based on the regulatory approvals that have been, and are expected to be, received by the expected closing date. Following the closing, the parties will continue to work to obtain, and expect to receive, the requisite approvals for TerrAscend to ultimately acquire ownership of all of the Licensed Operators. Until such time, TerrAscend's wholly-owned subsidiary will operate the Gage business through existing service agreements with the Licensed Operators. The disinterested directors of each of the TerrAscend and Gage boards determined that it is in the best interests of the respective companies to make the Amendments to facilitate closing of the Transaction at this time, given the strong approval obtained from the shareholders of both companies for the Transaction and the anticipated synergies and benefits to TerrAscend from the Transaction.

09:33 EST State Street to develop digital custody in collaboration with Copper.co - State Street announced that State Street Digital, the firm's dedicated Digital division, has entered into a licensing agreement with Copper.co, a London-based provider of institutional digital asset custody and trading infrastructure. "State Street Digital will leverage Copper.co's technology to develop and, subject to receipt of regulatory and other approvals, launch an institutional grade digital custody offering where clients can store and settle their digital assets within a secure environment operated by State Street. The firm will leverage its robust infrastructure and vast experience to assist clients' transition and thrive in the new digital economy," the company said. State Street's product offering is subject to regulatory approval, the company added. "As institutional investors' interest in digital assets continues to grow, we are building the financial infrastructure needed to support our clients' allocations to this new asset class. State Street Digital's mission continues to focus on putting the right tools in place so we can provide clients with solutions to support their traditional, as well as digital assets needs. Today's exciting announcement will only enhance our ambition to deliver to our clients an amazing digital experience. We look forward to collaborating with the team at Copper as State Street Digital continues to grow," added Nadine Chakar, head of State Street Digital.

09:31 EST Diversey Holdings trading halted, volatility trading pause

09:20 EST LightPath receives military qualification for Black Diamond DLC - LightPath announced that its Diamond Like Carbon, or DLC, coating process for its proprietary Black Diamond chalcogenide-based material to manufacture infrared lenses has now been qualified for all U.S. military applications.

09:13 EST Altamira Therapeutics receives approval to commence trial of Bentrio in Covid-19 - Altamira Therapeutics announced that its affiliate, Altamira Medica, has received the necessary approvals to initiate a clinical investigation of Bentrio in COVID-19 patients. COVAMID is a randomized, placebo controlled clinical trial to evaluate the ability of Bentrio nasal spray to reduce the SARS-CoV-2 viral load in the nose, alleviate COVID-19 signs and symptoms, and decrease the frequency of COVID-19 related hospital admissions. In the COVAMID trial, 136 confirmed COVID-19 patients will be randomized at a 2:1:1 ratio to receive for 10 days either Bentrio, a placebo, or no treatment, followed by a 10-day observation phase. Based on a planned blinded interim analysis, the number of participants may be increased to a maximum of 180 COVID-19 patients. The COVAMID study will start immediately in Bulgaria, and pending further approvals, it may be extended to two additional countries.

09:12 EST Papa John's suspends operations in Russia - Papa John's issued the following statement: "Papa John's stands with much of the globe in condemning aggression and violence. We hope for a peaceful resolution to the crisis in Ukraine, which today is hurting millions of innocent people, who are losing their homes, communities and people they love. Papa John's is committed to providing aid to those in the greatest need. We are actively supporting humanitarian efforts through financial contributions as well as by donating dry goods and ingredients to feed refugees in Eastern Europe through our partnership with World Central Kitchen. Papa John's has suspended all corporate operations in Russia. It has ceased all operational, marketing and business support to, and engagement with, the Russian market, where all restaurants are owned by independent franchisees, and a master franchisee who controls operations and provides all supplies and ingredients for the restaurants through a supply chain that it owns and operates. Papa John's International is not currently receiving any royalties from these franchised stores in Russia. Papa John's International does not own or operate any restaurants in Russia."

09:09 EST Sidus Space announces successful completion of LizzieSat PDR - Sidus Space is pleased to announce the successful completion of the LizzieSat Preliminary Design Review. A PDR ensures the design and basic system architecture are complete and that there is technical confidence the capability need can be satisfied within cost and schedule goals. A successful PDR means that a satellite is on track and development is progressing as planned. The LS satellites are partially 3D manufactured Low Earth Orbit microsatellites focused on rapid, cost-effective development and testing of upcoming innovative spacecraft technologies for multiple customers and space-based data collection. LS is a 100kg satellite with space to rapidly integrate customer sensors and technologies. "Our Sidus Space engineers did an excellent job preparing for and executing the PDR, and we are following up with briefings to our payload partners and strategic teammates," said Jamie Adams, Chief Technology Officer for Sidus Space. "With the PDR complete, our engineering team is one step closer to finalizing and readying for the initial launch in a planned fleet of 100 satellites capable of hosting a variety of custom payloads for a variety of customer missions and collecting space-based data for multiple industries."

09:08 EST Sophia Genetics' HRD testing technology adopted by Sofiva Genomics - Sophia Genetics' technology to support HRD testing has been adopted by Sofiva Genomics, one of the largest genetic testing companies in Taiwan aiming to provide genetic testing to clinicians. Sofiva is the first institution in Asia Pacific to do so. HRD is a complex biomarker, important for PARP inhibitors that help identify whether cancer patients may respond better to specific treatments.

09:07 EST Pitney Bowes and Ambi Robotics sign $23M last-mile deployment expansion in U.S. - Pitney Bowes and Ambi Robotics, a robotic sorting systems for supply chain operations company, announced a $23M deployment expansion of AmbiSort systems in Pitney Bowes ecommerce hubs across the US. The AI-powered robotics will help Pitney Bowes speed parcel sortation to last-mile delivery providers, while improving productivity, accuracy and worker safety as the company's shipping and ecommerce businesses surpass 50% of total revenue. Pitney Bowes will make the investment in Robot as a Service, RaaS, fees over the next four years. The expansion follows a successful deployment at the Pitney Bowes Stockton, Calif. ecommerce hub, where Pitney Bowes used AmbiSort systems to successfully sort parcels during the 2021 peak holiday season, nearly doubling the throughput for parcel sortation to local direct delivery units. "As we continue to scale our Global Ecommerce business, Pitney Bowes is working with some of the most innovative companies in the industry to configure new solutions that improve our service offerings and make B2C ecommerce logistics easier for our clients," said Gregg Zegras, EVP and President of Global Ecommerce at Pitney Bowes. "The deployment of AmbiSort AI-powered systems is part of our long-term plan to further enhance our technologically efficient, employee and client-friendly ecommerce logistics network."

09:05 EST Carvana launches new car vending machine in California - Carvana launched its newest car vending machine, located in Escondido, California. The white brick and glass structure stands eight stories tall with a 27-vehicle capacity.

09:04 EST Arcimoto partners with University of Central Florida to study transportation - Arcimoto announced a partnership with the University of Central Florida Future City Initiative to study new models of sustainable transportation and their place in the smart cities of the future. The company has provided UCF with an electric vehicle that could aid engineers in their work to find new transportation solutions for cities and urban environments. "We're thrilled to work with the University of Central Florida, one of the leading transportation research universities in the world," said Mark Frohnmayer, Arcimoto Founder and CEO. "The Future Cities Initiative is particularly exciting as it combines advanced technologies and new civil engineering practices to create smart cities that are safer, more efficient, and a joy to live and work in. We believe their efforts will demonstrate the importance of pure-electric rightsized vehicles and their place in the cityscapes of the future."

09:04 EST Target announces 'Target Zero' initiative to help reduce waste - Target announced Target Zero, a new initiative that responds to growing guest interest in products that help reduce waste. Guests will now see a Target Zero icon in stores and online that will signal products and packaging across Target's assortment designed to be refillable, reusable, or compostable, made from recycled content, or made from materials that reduce the use of plastic. Hundreds of new and existing products from guest-favorite brands across Target's Beauty, Personal Care and Household Essentials categories will be among the first in the Target Zero collection, with plans to expand the assortment in the future. Target Zero advances key commitments made through Target Forward, Target's sustainability strategy that aims to co-create an equitable and regenerative future with its guests, partners and communities, and includes ambitions to design and elevate sustainable brands and innovate to eliminate waste. The initiative uses Target's size, scale and resources to curate a one-of-a-kind assortment that drives innovation and progress to reduce waste.

09:03 EST STMicroelectronics releases economical radiation-hardened ICs - STMicroelectronics is simplifying the design and volume production of the new generation of reliable small, low-cost satellites to deliver services like earth observation and broadband internet from low-earth orbits. ST's new series of radiation-hardened power, analog, and logic ICs in low-cost plastic packages provide important functions for the satellites' electronic circuitry. The first nine devices in this series have just been released and include a data converter, a voltage regulator, an LVDS transceiver, a line driver, and five logic gates that are used throughout systems like power generation and distribution, on-board computers, telemetry star trackers, and transceivers. ST will continue to grow the series adding more functions in the coming months to further expand designers' choices. Prices for ST's new LEO series components range from $70 for logic ICs to $450 for the data converter for orders of 1000 pieces through ST distribution partners. Development Model prices are from $135 to $775 for 10 pieces. Please contact your local ST sales representative for specific pricing information.

09:02 EST BM Technologies appoints Jim Dullinger as CAO - BM Technologies announced that Jim Dullinger has joined as Chief Accounting Officer. In his newly appointed CAO role, Dullinger will collaborate closely with other members of the senior leadership team to ensure the integrity of the company's accounting, external reporting, and financial operations and support the company's ability to continue to scale for the future. Prior to joining BMTX, he served for more than two years as Chief Financial Officer at a publicly traded provider of data analytics software and wireless communications infrastructure services.

09:01 EST Qualcomm raises quarterly dividend 10% to 75c from 68c per share - Qualcomm announced that its Board of Directors has approved a 10% increase in the company's quarterly cash dividend. The quarterly cash dividend will increase from 68c to 75c per share of common stock and will be effective for quarterly dividends payable after March 24. This dividend increase will raise the annualized dividend payout to $3.00 per share of common stock.

08:54 EST Philip Morris suspends investments in Russia, to scale down operations - Philip Morris announced the suspension of its planned investments in the Russian Federation, including all new product launches and commercial, innovation, and manufacturing investments. PMI has also activated plans to scale down its manufacturing operations in Russia amid ongoing supply chain disruptions and the evolving regulatory environment. We will continue to monitor the situation as it evolves. "We have watched with shock the war in Ukraine and condemn the violence in the strongest possible terms. We stand in solidarity with the innocent men, women, and children who are suffering," said Jacek Olczak, CEO. "We join the many voices calling for an immediate end to the war and the restoration of peace."

08:48 EST Leon County Sheriff's Dept joins Sparta's Municipal Lease program - Sparta Commercial Services announces that Leon County, Florida Sheriff's Department chose Sparta's Municipal Lease program to finance a fleet of Harley-Davidson police motorcycles. By enabling municipalities to pay the cost of equipment over time, Sparta helps local government agencies lower their annual capital outlays to acquire critical equipment. Sparta continues to offer financing options that meet the needs of municipalities across the country.

08:45 EST FINCANNA CAPITAL's QVI provides update on Cherry Kola Farms JV - FinCanna Capital Corp. is pleased to provide an update on the Joint Venture between FinCanna's investee company QVI and Cherry Kola Farms. The Joint Venture includes a 50/50 profit share, which will drive revenue for both companies derived from the sales of Cherry Kola Farms live rosin products and West County Brands live rosin products that will be co-labelled with Cherry Kola Farms. The initial late-February market introduction of Cherry Kola Farms' live rosin products was targeted at a core group of dispensaries to allow for direct feedback from customer interactions. Response from dispensary owners, budtenders and consumers was unanimously positive as evidenced by a rapid sellout and re-orders received from each participating retail location. Based on this initial success, market expansion and penetration initiatives are underway with direct sales & marketing support and brand ambassadorship from Petalfast and industry leading distribution services from Calyx Brands, that jointly have connections to 1,100 retail and delivery locations across California. This near-term inaugural market expansion program is focused on 40+ dispensaries in select southern and northern California markets with further market expansion to follow. Cherry Kola Farms' premium live rosin products manufactured at West County Brands, are created with only the finest fresh frozen cannabis. Cherry Kola Farms utilizes the highest quality equipment and processes and finest input materials, including its proprietary genetics, Kola Classics and Kola Collab strains, which are bred to create high efficacy concentrates and unique flavor profiles. Cherry Kola Farms is also directing the production of West County Brands, MYTHC Life and GOTHC Life live rosin products ensuring select biomass acquisition and superior production practises. Additionally, initial market introduction of West County Brands own MYTHC Life live rosin products is being launched in conjunction with Cherry Kola Farms market expansion program with Calyx Brands and Petalfast. MYTHC Life's live rosin products are co-labelled with Cherry Kola Farms, bringing instant brand credibility with dispensary owners, budtenders and consumers. This is especially advantageous for MYTHC Life as it leverages its connection to Cherry Kola Farms premium priced products, and MYTHC Life is disruptively priced at approximately 50% discount to current market prices establishing a unique and compelling position in the market.

08:43 EST Lifeist Wellness' Mikra begins presales of CELLF - Lifeist Wellness announced a number of business updates regarding its wholly owned U.S. subsidiary, Mikra, Cellular Sciences, including the commencement of presales in the U.S. for its novel cellular therapeutic compound, CELLF, targeted at combating oxidative stress. Mikra, Cellular Sciences has commenced its genomic and transcriptomic clinical trials to gather evidence for CELLF at a molecular and cellular level. Lifeist has approved a budgetary allocation to Mikra of up to $8.5 million for the fiscal year 2022, subject to ongoing achievement of internal milestones governing each new product, and assuming reinvestment of all anticipated Mikra profits back into Mikra. With a waitlist of over 40,000 subscribers and positive feedback at levels of testing, Mikra has launched presale of its innovative cellular therapeutic CELLF to help combat oxidative stress, which may manifest in symptoms such as systemic fatigue, inflammation, and brain fog. Monthly subscriptions at www.wearemikra.com start at $88.00 + applicable taxes, for a 30-day supply of 10ml single-serve sachets, with sales on Amazon USA targeted to commence shortly afterward. With respect to distribution in Canada, Mikra is in the process of obtaining a Natural Product Number from Health Canada. Subject to NPN receipt, Mikra anticipates launching a Canadian retail distribution strategy in calendar Q3 2022.

08:41 EST ION says holders of second priority 2025 notes purchase indebtedness to PNC - ION Geophysical Corporation announced that PNC Bank, National Association, has sold and assigned its commitment and outstanding loans under ION's Revolving Credit and Security Agreement dated August 22, 2014 to certain holders of ION's 2025 Notes. In addition, ION entered into a First Amendment to the Second Forbearance and Seventh Amendment to the Credit Agreement with the purchasing lenders pursuant to which, among other things, the purchasing lenders have agreed to extend the current forbearance through April 4, 2022. ION also announced that it had entered into Amendment No. 2 to the Forbearance Agreement with holders of more than 79% of its 2025 Notes to continue their forbearance through April 4, 2022. The forbearances are subject to the terms and conditions of the relevant agreements, which are described in more detail in our current report on Form 8-K that will be filed with the SEC. ION remains in continuing discussions with the holders of its 2025 Notes and other indebtedness regarding various strategic alternatives to strengthen its financial position and maximize stakeholder value. These strategic alternatives include, among others, a sale or business combination transaction or sales of assets, any of which may be executed as part of an in-court or out-of-court restructuring process.

08:39 EST Dentsply Sirona announces $150M accelerated share repurchase program - DENTSPLY SIRONA (XRAY) announced that it has entered into an accelerated share repurchase agreement, ASR, with Bank of America (BAC), National Association to repurchase $150M of its common stock. The ASR agreement will be completed under Dentsply Sirona's current share repurchase authorization. Under the terms of the ASR, Dentsply Sirona will initially receive delivery of approximately 2.4M shares. The final number of shares will be based on the average of the daily volume-weighted average stock prices of Dentsply Sirona common stock during the valuation period of the ASR, less a discount and subject to adjustments. The resulting adjustments may affect the total amount expended or the aggregate number of shares repurchased. Final settlement of the ASR is expected to be completed before the end of the second quarter of 2022, subject to acceleration.

08:39 EST Alcoa completes efficiency project at Deschambault smelter in Quebec - Alcoa "officially marked the completion of a capital project that is expected to improve stability, increase efficiency, and boost production at its Deschambault aluminum smelter in Quebec, Canada," said the company. The smelter has finished the installation of upgraded electrical infrastructure, the result of a $47M capital project to help the site continue to improve operations. The work included the addition of a third electrical transformer to provide more amperage to the smelting pots and enable increased metal production. In addition, upgraded environmental equipment will allow the plant to maintain environmental compliance as it works to increase aluminum production in the coming years. In 2019, the Canadian government, through its Strategic Innovation Fund, announced a CA$10 million contribution toward the project at Deschambault. The three smelters that Alcoa operates in Canada, Deschambault, Baie Comeau and Becancour, are certified to standards set by the Aluminium Stewardship Initiative, the industry's most comprehensive, third-party system to verify responsible production.

08:37 EST Harbor Custom Development completes senior secured revolving credit facility - Harbor Custom Development announced the closing of a senior secured revolving credit facility with BankUnited, Inc. The facility will provide the Company with a $25 million capacity over a two-year term. Piper Sandler served as Harbor's exclusive financial advisor. The Facility has a rate of SOFR plus 4.75%. The funds will provide the company additional resources to support general working capital requirements and general corporate purposes, including real estate equity investments.

08:36 EST Kinross Gold pours first gold bar at La Coipa - Kinross Gold announces that its La Coipa project in Chile achieved a significant milestone and poured its first gold bar. The project commenced commissioning at its plant in early February 2022, on schedule and under budget, with the plant expecting to ramp up over the next few months to reach full operating capacity mid-year. "Thanks to the hard work and contributions of our team in Chile, we were able to reach this important milestone and pour our first gold bar at La Coipa," said J. Paul Rollinson, President and CEO. "Our team has safely delivered the project on schedule and under budget despite the challenging operating environment caused by the global pandemic over the past two years. With La Coipa expected to reach full operating capacity by mid-year, we are on the cusp of further exciting milestones at the project." At year-end 2021, Kinross increased La Coipa's expected life of mine production by 45% to approximately 1M Au eq. oz. by incorporating the nearby Puren pit into the project and optimizing the Phase 7 mine plan. The project's life of mine estimate was also extended from 2024 to 2026. Pre-stripping at Puren is expected to begin in April 2022.

08:34 EST Graham announces Christopher Thome from Allied Motion Technologies joins as CFO - Graham Corporation (GHM) announced that Christopher Thome will join Graham Corporation as Vice President - Finance and Chief Financial Officer effective April 4. He joins Graham from Allied Motion Technologies (AMOT) where he served as Corporate Controller and Treasurer. He brings nearly 30 years of experience in finance and accounting leadership, audit, public company financial reporting, treasury, operational accounting and shared services implementation.

08:34 EST AST SpaceMobile signs multi-launch agreement with SpaceX - AST SpaceMobile announced it has signed a multi-launch agreement with SpaceX. In addition to the planned summer launch of the BlueWalker 3 test satellite, or BW3, the agreement covers the launch of the first BlueBird satellite and provides a framework for future launches.

08:32 EST Campbell Soup sees 2H net sales growth low to mid single digits - Sees double digit growth in adjusted EBIT, adjusted EPS in 2H.

08:32 EST Prelude Therapeutics announces presentation of new data at 2022 AACR meeting - Prelude announced that new preclinical data have been accepted for presentation at the upcoming 2022 American Association for Cancer Research, AACR, Annual Meeting being held April 8-13 in New Orleans, Louisiana. Summary of AACR Accepted Abstracts: Title: "PRT2527, a novel highly selective cyclin-dependent kinase 9 (CDK9) inhibitor, is active in preclinical models of prostate cancer." Conclusion: PRT2527 was evaluated in prostate cancer models. Collectively, the data demonstrate that PRT2527 had potent antitumor activity in multiple models of castration-sensitive and castration-resistant prostate cancer, inhibited Myc transcriptional activity and reduced tumor stem-like cells. Title: "Combination of the MCL1 inhibitor PRT1419 and SMARCA2 degrader PRT3789 shows combinatorial benefit in SMARCA4 deleted lung cancer." Conclusion: The abstract highlights new preclinical data demonstrating synergistic benefit when PRT1419 was combined with the Company's novel and selective SMARCA2 degrader, PRT3789, in SMARCA4 deleted lung cancer models. Combining PRT1419 and PRT3789 in vivo in cell line-derived xenograft models resulted in significant tumor growth inhibition, including tumor regressions. Title: "PRMT5 inhibitor PRT543 displays potent antitumor activity in U2AF1S34F and RBM10LOF spliceosome-mutant non-small cell lung cancer in vitro and in vivo." Conclusion: The abstract highlights in vitro and in vivo activity of PRT543 in cancer cells harboring mutations in spliceosome factors such as U2AF1 and RBM10, which occur in ~5-10% of all NSCLC. Title: "Brain penetrant CDK4/6 inhibitor PRT3645 demonstrates anti-tumor activity and enhances survival in glioblastoma and breast cancer brain metastasis models." Conclusion: This abstract highlights data from multiple preclinical studies showing that PRT3645 exhibits the desired balance of potency, selectivity, and brain penetration compared to approved CDK4/6 inhibitors. Title: "Preclinical characterization of PRT3789, a potent and selective SMARCA2 targeted degrader." Conclusion: The abstract describes the characterization of PRT3789, one of Prelude's potent and selective SMARCA2 targeted degraders. Treatment with PRT3789 demonstrated robust inhibition of SMARCA4-deleted non-small cell lung cancer cell growth but not SMARCA4 WT cancer cells, both in vitro and in vivo at well-tolerated doses.

08:29 EST BIO-key completes acquisition of Swivel Secure Europe - BIO-key International announced that it has completed the acquisition Swivel Secure Europe, S.A, a privately-held IAM solutions provider based in Madrid, Spain that serves European, Middle East and African markets. SSE generated approximately $3.1M in revenue and $578K in operating income in calendar 2021. SSE has a five-year exclusive distribution agreement for Swivel Secure Limited's software solutions in all EMEA markets outside of the United Kingdom. Alex Rocha, the CEO and former sole stockholder of SSE, will continue to manage day to day operations at SSE reporting directly to BIO-key's Chairman & CEO. The acquisition provides BIO-key with a ten member sales and support team with extensive customer and industry relationships throughout the EMEA region with offices in Madrid, Lisbon and UAE. SSE also brings technology partnerships with SAP, SailPoint and Red Hat, and global reseller partner relationships with Arrow, Deloitte, Accenture, Logicalis, IBM, Telefonica and Wipro.

08:26 EST Berkeley Lights announces CFO Wood to depart to pursue other another role - Berkeley Lights announced that Kurt Wood will be leaving the Company to pursue his expressed interest in a role outside of the biotech industry. He will continue to serve as chief financial officer, CFO, until April 1, 2022, and remain with the Company in an advisory capacity through April 30, 2022, to assist with the transition. The Company will initiate a search for a new CFO.

08:24 EST Carpenter Technology announces public offering of senior notes - Carpenter Technology Corporation announced that it has commenced an underwritten public offering of senior notes, subject to market and other conditions. The Company intends to use the net proceeds from the offering to repay in full its 4.450% senior notes due 2023. J.P. Morgan Securities LLC is acting as the lead book-running manager for the offering.

08:23 EST U.S. Court of Appeals hears World's oral argument on 3D virutal worlds patents - The Chief Judge and two other Judges of the U.S. Court of Appeals for the Federal Circuit heard oral arguments on March 8, 2022 in the appeal filed by Worlds Inc. (WDDD). Worlds has asked this Court to reverse an adverse District Court judgment from April 30, 2021 that favored defendants Activision Blizzard (ATVI), Blizzard Entertainment, Inc., and Activision Publishing, Inc. Worlds has been in litigation with the Activision defendants since 2012, with Worlds asserting that the Activision defendants infringed Worlds' patents directed to three-dimensional virtual world technology and network architecture. This litigation was stayed in 2015, while Worlds defended its patents against six validity challenges brought before the Patent Trial and Appeal Board. Worlds' patents all survived these challenges. In 2020, the litigation stay was lifted, and the parties progressed through extensive discovery until the District Court ruled that Worlds' patents were invalid under 35 U.S.C. Section 101 as directed to patent-ineligible subject matter. Worlds appealed. During the appeal oral argument, the Federal Circuit judges engaged both Worlds' attorney and Activision's attorney in a meaningful dialogue regarding the merits of Worlds' appeal. The judges acknowledged Worlds' past innovations and the news articles applauding Worlds' virtual reality development in early 1995, and inquired about the scope of the patent claims on appeal. Upon conclusion of the oral argument, the judges took the case as submitted, which means that the judges will privately reevaluate the briefs and arguments before deciding how to rule on the appeal.

08:20 EST Magnite named a preferred SSP, SpringServe as primary ad server by Plex - Magnite announced that Plex, the global ad-supported streaming media platform, has named Magnite as a preferred SSP and SpringServe as their primary ad server following impressive year over year revenue and user growth across both platforms. "Plex is at the forefront of both the FAST and AVOD landscape with over 200+ channels and 50,000 titles fully poised to take advantage of the accelerated growth of this ad supported sector of streaming. We're delighted to continue our relationship with Plex and help them grow their ad-supported business," said Mike Laband, SVP, CTV at Magnite. "The results thus far speak for themselves and we look forward to the continued upward trajectory of our collaboration."

08:18 EST Denali Therapeutics announces initiation of Phase 1/2 trial of DNL593 - Denali Therapeutic announced that dosing has begun in a Phase 1/2 clinical trial of DNL593 for the potential treatment of frontotemporal dementia, FTD, caused by mutations in the granulin gene, GRN. Pending initial clinical data from the Phase 1 healthy volunteer portion of the clinical trial, Denali expects to begin dosing individuals with FTD-GRN in the second half of 2022. Denali and Takeda have a strategic collaboration to co-develop and co-commercialize DNL593. FTD-GRN is characterized by progranulin deficiency in the brain. DNL593 is an investigational brain-penetrant, recombinant PGRN replacement therapy enabled by Denali's Protein Transport Vehicle. The therapeutic goal of DNL593 is to slow or prevent progression of FTD-GRN by increasing intracellular and extracellular levels of functional PGRN. "Denali has a diverse portfolio of therapeutic candidates to address neurodegenerative and lysosomal diseases, and DNL593 is our second Transport Vehicle technology-enabled program to enter clinical development," said Carole Ho, M.D., Denali's Chief Medical Officer. "Initiation of this Phase 1/2 trial is an important development milestone for the program, and we look forward to continued collaboration with Takeda and the FTD community in our unified purpose to develop DNL593 as a treatment option for people and families living with FTD-GRN."

08:17 EST Curtiss-Wright announces resolution with Saddle Point - Curtiss-Wright announced an agreement with Saddle Point Management pursuant to which Saddle Point has withdrawn its proposals and its nominees for election to the Company's Board of Directors at the Company's upcoming 2022 Annual Meeting of Stockholders. "We appreciated our engagement with Saddle Point and respect the significant work it has done as part of its approach to investing in our company," said Lynn M. Bamford, President and CEO of Curtiss-Wright Corporation. "We are always open-minded when it comes to value creation ideas presented by our shareholders. As we have done historically, our approach to Board refreshment will continue to seek the best and most qualified candidates that bring to bear the critical skills and values in light of our business, financial profile and our portfolio's increasing focus on Defense. We thank Saddle Point for its interest and input as a constructive Curtiss-Wright shareholder."

08:16 EST ImmunoPrecise Antibodies provides update on PolyTope TATX-03 IND program - ImmunoPrecise Antibodies reported on the latest progress in the development of their PolyTope TATX-03 antibody cocktail therapy with a proven strong efficacy against all tested SARS-CoV-2 variants-of-concern. The company reports data indicating their recent IND-enabling animal studies do not show any observable acute adverse events, data which supports a highly positive safety profile for TATX-03 as a clinical product. In addition, results from the FDA reviewed and recommended animal study protocols demonstrate that the in vivo pharmacokinetic profiles of the individual antibodies show no aberrations, and each antibody demonstrates a characteristic human IgG1 pharmacokinetic profile. As a prelude to a formal toxicology study, a maximum tolerated dose and a pharmacokinetic study were completed using injections of up to 12.5 times the anticipated highest dose proposed for the phase 1 clinical trial. The results did not demonstrate any adverse clinical signs, nor any observable effect in behavior, change in appetite, or change in weight, in any of the animals. In addition, monitored vitality indicators, such as body temperature, stayed within their respective physiological ranges, and no post-mortem macroscopic tissue anomalies were observed. In vivo animal serum profiles of each antibody were in full accordance with those expected for human immunoglobulins. To promote IND approval and a seamless transition to the clinic, the company engages in on-going communications with the FDA regarding the TATX-03 data package. The FDA has advised to enhance the preclinical safety evaluation by examining the build-up of antibody serum concentrations in the laboratory animal model versus humans, recommending a study design adaptation to increase the number of injections and to monitor the elimination of antibodies from the animals. The ongoing final GLP toxicology study is therefore extended by eight weeks with the final data being available mid-June, 2022. These current advancements allow scheduling of investigational new drug filing to the FDA early Q3. Importantly, the timelines for completion of clinical batch production nor the launch of the intended phase 1 clinical trial are not impacted and on schedule as planned.

08:15 EST Campbell expects improvement in margins, profit, EPS in balance of year

08:15 EST LabCorp enters into strategic relationship With Prisma Health - Labcorp is entering into a strategic laboratory relationship with Prisma Health, a nonprofit and the largest health system in South Carolina. Through this new relationship, Labcorp will acquire select assets of Prisma Health's outreach laboratory business. In addition, Labcorp and Prisma Health have entered into a technical support agreement to apply Labcorp's knowledge and expertise in Prisma Health's hospital laboratories. Collectively, the strategic collaboration enhances Labcorp's diagnostic footprint and capabilities in the Carolinas and allows Prisma Health's patients and providers the benefit of enhanced care across multiple clinical areas. The strategic relationship will expand Prisma Health patients' access to laboratory testing throughout South Carolina and offer individualized, dedicated support to physician practices. It follows other strategic collaborations with local and regional health systems that have enabled Labcorp to enhance service for patients and providers.

08:15 EST Campbell Soup sees 'strong' y/y performance in 2H

08:12 EST Sensus Healthcare announces $3M share repurchase program - Sensus Healthcare announces that its Board of Directors has authorized a program to purchase up to $3,000,000 of shares of its Common Stock. Commenting on this new program, Joe Sardano, chairman and chief executive officer of Sensus Healthcare, said, "With optimism about the future of Sensus, along with the business tracking toward sustained profitability, it just makes sense to invest in ourselves. Acquiring our own shares is one of the ways we plan to use our resources to continue to build shareholder value. Our financial performance, disciplined and thoughtful approach to capital allocation and expenses, and overall strength of our balance sheet give us both the confidence and the flexibility to execute this share repurchase program."

08:12 EST Genius Sports announces partnership with Mid-American Conference - Genius Sports has secured an official sports data, fan engagement and integrity partnership with the Mid-American Conference, or MAC, a National Collegiate Athletic Association, or NCAA, Division I Conference that sponsors championships in 24 sports. As the Exclusive Supplier of Official NCAA Data, Genius Sports will capture, manage and distribute official MAC statistics, providing the fastest and most reliable feed on thousands of competitions a year. This partnership will help to create more immersive and engaging fan experiences, powered by Genius Sports' data collection and fan engagement solutions. NCAA LiveStats, the NCAA's official tool for the collection, management, and distribution of official game statistics, will be rolled out for all MAC competitions. Genius Sports will provide the MAC with a robust integrity program, helping to maintain the transparency and fairness of its events. Genius Sports will conduct a comprehensive audit of the MAC's existing integrity procedures while also implementing 24/7 monitoring and a series of educational workshops to MAC players, officials, and athletic departments.

08:11 EST Aemetis begins commissioning of biogas to RNG upgrading facility - Aemetis announced the commencement of commissioning of the $12 million biogas-RNG upgrading facility connected to the PG&E gas pipeline interconnection unit located at the Keyes ethanol plant site. The full system commissioning process, including PG&E's interconnection unit, is expected to be completed in April 2022, enabling the production of utility-grade renewable natural gas for sale to customers via pipeline delivery. In the Five Year Plan released on February 28, 2022, Aemetis plans to invest more than $300 million to build 66 dairy digesters and more than 36 miles of biogas pipeline to produce more than 1.5 million MMBtu of dairy renewable natural gas each year. The biogas-RNG upgrading facility and the PG&E interconnection unit are designed to convert the dairy biogas into utility-grade, pressurized natural gas for use as a transportation fuel.

08:09 EST DatChat receives notice of allowance for blockchain-based communication systems - DatChat announced that it has received a notice of allowance from the USPTO for patent application 16/736,858 for a "Blockchain-Based Communication Systems and Methods." The "Blockchain-Based Communication Systems and Methods" covers a blockchain-based communication platform, micro-blockchains for direct peer-peer secure communications, ephemeral micro blockchain messaging, control of messages after being sent and a digital rights management engine.

08:08 EST CAE partners with Joby Aviation to develop eVTOL aircraft pilot training - CAE (CAE) has partnered with Joby Aviation (JOBY) to develop and qualify flight simulation training devices that will be used to train the future pilots of Joby's all-electric aircraft. Leveraging the core simulation technology Joby has been developing for the past five years, CAE will work with Joby to develop pilot training devices specifically for the company's electric vertical take-off and landing - eVTOL - aircraft. Joby intends to both manufacture and operate its aircraft, requiring the company to train a new generation of pilots.

08:07 EST VSE Corp. awarded $100M NAVSEA contract - VSE Corp. announced that its Federal and Defense segment has been awarded a 12-month, $100M contract by Naval Sea Systems Command, or NAVSEA. VSE is the current contractor providing Foreign Military Sales, or FMS, follow-on technical support to NAVSEA and has the technical capability, customer knowledge and expertise to execute repair and maintenance of critical foreign assets. Under the terms of the contract award and in conjunction with NAVSEA's International Fleet Support Program Office, VSE will continue to support eligible foreign navies with a broad range of aftermarket services. Specifically, VSE will provide aftermarket services, such as life cycle optimization, integration support, systems upgrades, and supply chain distribution.

08:06 EST DarioHealth announces two new contracts - DarioHealth announced new agreements with a regional employer and a regional provider. The contracts are expected to launch in the second quarter of 2022. Dario's digital therapeutic platform integrates digital tools, medical devices, and digital and human coaching across one experience, delivering a seamless user journey for employees to help them change their behavior to better manage their chronic conditions. The new employer client will deploy Dario's digital behavioral solution to improve access to outcomes-based care, and the new provider contract will deliver both diabetes and hypertension solutions to patients.

08:05 EST Leidos awarded seven-year NIAID contract to support biomedical research - Leidos was awarded a new prime contract to provide biomedical preclinical and development capabilities to support the National Institute of Allergy and Infectious Diseases. The seven-year, multi-award, indefinite delivery/indefinite quantity contract has an approximate value of up to $545M across all task areas to be engaged on this program. Leidos will provide a suite of biomedical, preclinical and development capabilities and capacity to the NIAID.

08:05 EST Campbell Soup: No direct exposure to Ukraine or Russia

08:04 EST Baker Hughes announces order for LNG system - Baker Hughes has been awarded a contract and granted notice to proceed by Venture Global LNG to provide a liquefied natural gas, or LNG, system for the first phase of the Plaquemines LNG project in Louisiana. The highly-efficient liquefaction train system, or LTS, supplied by Baker Hughes is modularized. Baker Hughes manufactures, tests and transports the pre-assembled and fully integrated modular turbomachinery units for Venture Global LNG at its manufacturing and assembly facilities in Italy. As part of the scope, Baker Hughes will also provide field services to assist in commissioning of the supplied equipment. This order builds on an award in the fourth quarter of 2021 for Baker Hughes to provide power generation and electrical distribution equipment for the comprehensive power island system of Venture Global LNG's Plaquemines LNG project.

08:03 EST Medtronic signs contract to add Touch Surgery Enterprise to Vizient - Medtronic has entered into a contract with Vizient, a healthcare performance improvement company in the U.S., to add Touch Surgery Enterprise to Vizient's offerings, which serve more than half the nation's healthcare providers. The first AI-powered surgical video management and analytics platform for the operating room, Touch Surgery Enterprise aims to simplify the process of recording, analyzing, and sharing surgical video, A fully integrated hardware and software system connected to the cloud, Touch Surgery Enterprise works with many laparoscopic and robotic scopes. Touch Surgery Enterprise is part of Medtronic's portfolio of artificial intelligence and surgical robotic solutions. It is compatible with the Hugo robotic-assisted surgery system.

08:02 EST Hall of Fame Resort & Entertainment appoints Benjamin Lee as CFO - Hall of Fame Resort & Entertainment (HOFV) announced it has appointed Benjamin Lee as its new CFO, effective March 21. Lee will be responsible for all financial aspects of the company's operations, including accounting, financial reporting, tax, treasury and capital raising. Lee most recently served as the CFO of the Capital Markets and Debt Products divisions at PNC Financial (PNC).

07:56 EST Skeena Resources announces drilling results from Eskay Creek project - Skeena Resources is pleased to announce final drilling results from the 2021 regional and near mine exploration programs at the Eskay Creek gold-silver Project in the Golden Triangle of British Columbia. New 2021 Exploration Program Highlights: 1.29 g/t Au, 36 g/t Ag over 14.50 m; 0.79 g/t Au, 26 g/t Ag over 21.11 m; 1.77 g/t Au, 200 g/t Ag over 11.73 m; 0.78 g/t Au, 120 g/t Ag over 11.50 m; 8.78 g/t Au, 13 g/t Ag over 34.00 m. Following up on resource category conversion drilling performed in early 2021, exploratory drill hole SK-21-997 intersected high-grade gold mineralization averaging 8.78 g/t Au, 13 g/t Ag over 34.00 m located 60 m west of Skeena's current 21A Zone pit-constrained resources. Hosted entirely within the rhyolite sequence, this new mineralization is only 30 m vertically below surface. This discovery remains open for expansion 120 m to the north and already occurs within the limits of the contemplated open-pit from Skeena's 2021 Prefeasibility Study. The high-grade gold and essentially negligible silver concentrations in this new intersection is uncharacteristic of rhyolite hosted mineralization at Eskay Creek. "Due to a lack of drilling, this new discovery which expands the 21A Zone to the west, was considered waste rock in the currently proposed PFS reserve pit area," notes Paul Geddes P.Geo., the Company's Vice President of Exploration and Resource Development. "We will work to expand and infill drill the 21A West Zone and potentially bolster the pit-constrained resources surrounding this newly discovered mineralization".

07:51 EST Dorman Products announces 250 new products for March - Dorman Products is announcing the release of 250 new auto parts, including more than 100 new-to-the-aftermarket parts that advance the company's mission of giving repair professionals and vehicle owners greater freedom to fix a wide range of cars and trucks. This month's new product releases include two Dorman OE FIX transmission control modules remanufactured in the USA and designed to fit more than 1.6M late-model Ford Fiesta and Focus cars. Dorman's newest OE FIX fuel pump driver module offers feature upgrades compared to the original equipment driver module on more than 1.2 million GM vehicles. Extending coverage in all-in-one assemblies designed to save technicians labor time and money, a new windshield wiper motor and transmission assembly is designed to fit 1.6+ million GM cars. Dorman is also introducing five new hard-to-find parts covering a combined total of more than five million cars and trucks.

07:49 EST Pipestone Energy updates 2022 guidance, three-year development plan - As a result of successful Central Block delineation, strong capital program execution and a supportive commodity price environment, Pipestone has revised its 3-year business plan to modestly increase capital spend within cashflow that results in additional production growth through 2024 and beyond. To facilitate this growth, the Company has secured incremental raw gas processing capacity, which it expects to be available in Q3 2023, facilitating a new production upper boundary of approximately 46,000 boe/d. In aggregate over the three years, Pipestone forecasts to spend $555 million on capital, while generating $1,150 million in cash flow, resulting in approximately $600 million of free cash flow, which equates to approximately 40% of the Company's current fully diluted market capitalization. 3-year plan as at March 2022, derived by utilizing, among other assumptions, historical Pipestone Energy production performance and current capital and operating cost assumptions held flat for illustration only. Budgets and forecasts beyond 2022 have not been finalized and are subject to a variety of factors and as a result, forecast results for 2023 and 2024 may change materially. Where a range is not provided, guidance and forecast values represent the mid-point estimate. Each US$10 per barrel change in WTI prices equates to an ~$40 million change in 2022 free cash flow, and each C$0.50 per GJ change in AECO natural gas price equates to an ~$20 million change in 2022 in free cash flow. For 2022, largely as a result of processing capacity constraints and increased lift gas utilization, Pipestone is reducing its production guidance range by 8% to 31,000 - 33,000 boe/d. Production was disrupted for 18 full days in January and February at the Keyera Wapiti Gas Plant, as a result of both weather-related and mechanical issues. Opportunities to recover the calendar year production will be restricted during Q2 and Q3, as all three midstream plants Pipestone is connected to are planning major plant turnarounds. Additionally, interruptible processing capacity availability is expected to be more limited during H2 2022, as other area operators grow production volumes. By Q4 2022, the Company expects to be fully utilizing its currently available processing capacity, and expects to average approximately 37,000 boe/d over the quarter. Production is forecast to grow to 40,500 boe/d in 2023 as planned new processing capacity becomes available in Q3 of that year, resulting in exit volumes of approximately 45,000 boe/d, which based on the revised processing limitations are expected to be maintained through 2024. Pipestone is also increasing its 2022 capital guidance range to $210 - $220 million. This revised capital program is funded well within cashflow and will further delineate Pipestone's asset while accelerating Pipestone's growth into 2023. The expanded capital program will include: Increased infrastructure expenditures, including a pipeline to the 6-33 step-out pad Inc;reased drilling and completion activity in H2 2022; and Completion and long-term test of the drilled, but uncompleted Montney delineation well at 12-36 during Q2 2022. Including the additional capital, Pipestone still forecasts to generate $130 - $140 million of free cash flow in 2022. The previously released year-end 2021 McDaniel 2P reserve report includes 149 undeveloped locations, which supports growth to approximately 45,000 boe/d and that could be held flat until 2032. Pipestone has internally identified an additional 160 Tier 1 net unbooked locations on its Central and Eastern acreage blocks, that would support further growth to a risked plateau of approximately 55,000 boe/d by exit 2025, with a plateau period of approximately 10 years. To achieve this production level, Pipestone will have to continue to contract incremental processing capacity. The Company estimates there to be approximately 250 MMcf/d of currently available or planned sour gas processing expansions in the Pipestone area that could be in-service by 2025. Pipestone has pivoted from being a net consumer of capital to a net generator of free cashflow. As previously announced, Pipestone's first priority for its free cashflow in 2022 is to deleverage the business, with a corporate debt target of less than $100 million, which equates to less than1.0x D/CF at a US$45 WTI $2.00 AECO. Pipestone expects to achieve this target by mid-year. In conjunction with de-leveraging, Pipestone has commenced an NCIB to repurchase up to 5% of its basic shares or approximately 10 million shares over a 12-month period from commencement in November 2021. After de-leveraging and executing on its NCIB, Pipestone expects to generate additional free cash flow in 2022 that will be available for additional debt re-payment and/or shareholder returns or additional capital to expand the business.

07:47 EST Embraer informs impact from Russia-Ukraine conflict - Embraer informed the market about the impacts in its business and operations resulting from the Russia and Ukraine conflict. The company has suspended parts, maintenance, and technical support services for certain customers to comply with the sanctions imposed on Russia, Belarus, and certain regions of Ukraine by laws of jurisdictions to which Embraer is subject. In addition, Embraer informs that there is no immediate concern over the availability of titanium in its supply chain, considering its strong current inventory position and the existing contracts for the provision of this material with companies in other countries. Embraer will continue to monitor its supply chain and to seek alternative sources.

07:46 EST Shyft Group debuts Blue Arc EV Solutions - Blue Arc EV Solutions, a new go-to-market brand of The Shyft Group, makes its debut today alongside a trio of initial product offerings-an industry-first commercial grade purpose-built EV chassis; a fully reimagined from the ground up all-electric Class 3 delivery walk-in van; and a fully portable, remote-controlled charging station, the Power Cube. The Blue Arc delivery van is a 100% battery-powered Class-3 electric commercial delivery vehicle, designed for high-frequency, last-mile delivery fleets. A spacious cargo area features 635-800 cubic feet of storage and offers a choice of vocational packages specifically designed for functionality. The delivery van also features an integrated solar roof package and lightweight aluminum honeycomb shelving package 175lbs lighter than today. Vehicle prototypes are expected to reach customers for route testing in the coming months, supported out of the Shyft R&D facility in Plymouth, Mich. Shyft expects to begin building the chassis and electric delivery vans at a plant in the southeastern United States by mid-2023. The Blue Arc ecosystem also includes the Power Cube, a fully portable remote-controlled charging station with onboard energy storage to serve a variety of commercial vehicle needs.

07:43 EST General Electric announces $3B share repurchase program - In a regulatory filing, GE said, "On March 6, 2022, the Board also provided an authorization for up to $3 billion of common share repurchases. GE expects to consider share repurchases as one of a number of potential capital allocation alternatives on an ongoing basis, along with organic and inorganic investments, as we plan to establish three global, investment grade companies."

07:42 EST FTI Consulting announces updates to Connect and Universal Messaging Platform - FTI Consulting announced extensive updates to its Technology segment's Connect and Universal Messaging Platform solutions. Connect is a proprietary platform built by FTI Technology's emerging data sources experts to drive faster access to insights and support rapid integration into cloud data sources, including Microsoft 365, Google Workspace, Slack and Box. The Universal Messaging Platform allows FTI Technology's e-discovery and investigations experts to deliver efficient workstreams that identify, preserve, collect, process, review and produce information from more than 15 cloud-based emerging data sources. As emerging data sources grow in volume, variety and velocity, they are introducing an increasing range of challenges in e-discovery and investigations. An average of 400 data sources are in play at any given organization, and IDG Research found that more than 20% are juggling data from 1,000 or more sources. The research also found that at the current trajectory of data growth, the majority of data within an enterprise will be from cloud-based, emerging data sources by 2023. This is prompting the need for significant changes in best practices, workflows and technology capabilities across discovery, investigations, risk and compliance.

07:39 EST AIM ImmunoTech announces abstract on ampligen to be presented at AACR 2022 - AIM ImmunoTech announced that data from the ongoing Phase 2 cisplatin-resistant advanced recurrent ovarian cancer clinical study utilizing Ampligen was accepted for presentation at the American Association for Cancer Research, AACR, Annual Meeting 2022, being held April 8-13, 2022, in New Orleans, Louisiana. Details of the abstract presentation are as follows: Title: Combined loco-regional and systemic, triple agent chemoimmunotherapy increases biomarkers of T cell chemotaxis in ovarian cancer. The investigator initiated, Phase 2, single arm, efficacy/safety trial to evaluate the effectiveness of combining intensive locoregional intraperitoneal chemoimmunotherapy of cisplatin with IP Ampligen and IV infusion of the checkpoint inhibitor pembrolizumab for patients with recurrent platinum-sensitive ovarian cancer is being conducted by the University of Pittsburgh Medical Center. A total of 17 patients were enrolled and 13 were evaluable for response in the ongoing Phase 2 trial. The MesoScale Delivery platform was used to profile different biomarkers in the peritoneal samples throughout treatment. The observed clinical responses were: 2 complete responses, 3 partial responses, 3 stable disease, 5 progressions for a clinical benefit rate of 61.6%. From 13 patients, 77 IP wash samples were collected at serial time points. MSD measurements in IP washes revealed an acute increase in granzyme B, perforin, TNF alpha, CXCL9, CXCL10, CXCL11 after treatment. Longitudinal data revealed a progressive increase in some biomarkers in the locoregional environment; CXCL9, CXCL10, CXCL11, perforin and TNF alpha were all increased from baseline levels at cycle 1 to baseline of cycle 6. CXCL12 was also increased acutely after treatment.

07:36 EST Akari Therapeutics announces new preclinical data published on vovotucalis - Akari Therapeutics announced new preclinical data published in Frontiers in Pharmacology demonstrating that Akari's pipeline candidate votucalis has potential as a treatment for pain and itch associated with conditions such as atopic dermatitis, psoriasis and neuropathic pain. Votucalis is a broad-acting histamine inhibitor that was discovered through the same research program that yielded Akari's lead drug, nomacopan, a complement and leukotriene inhibitor currently in Phase III clinical development. Clive Richardson, CEO of Akari Therapeutics, said: "The unique inhibition of the histamine pathway by votucalis affords Akari the potential to expand our existing dermatology franchise as well as exploring votucalis as a treatment for pain where current treatments such as opioids can be ineffective and can have serious side-effects including addiction. We look forward to continuing our collaboration with Durham and Newcastle Universities to move this program forward." The data published today were from two preclinical models of itch and pain in mice. In pain, votucalis produced a potent and complete anti-sensation effect in a mechanical hypersensitivity model. Local administration of votucalis was achieved at significantly lower doses and produced a longer duration of effect than systemic administration. The research also showed that Votucalis does not enter the brain. In itch, votucalis provided inhibition of histaminergic itch of around 62%, with the potential for greater reduction with higher dosing. Peripheral H1 and H2 or central H4 antagonism inhibited histaminergic itch of around 64%, 53% and 27 %, respectively. When peripheral antagonists were combined with votucalis, itch was reduced between 80% and 90%.

07:35 EST Kinetik Holdings announces pricing of upsized secondary offering APA Corp. - Kinetik Holdings announced the pricing of an upsized underwritten secondary offering of 3,478,261 shares of its Class A common stock by Apache Midstream, a subsidiary of Apache Corporation, at a price of $58.00 per share. Kinetik is not selling any shares of Class A common stock in the Offering and will not receive the proceeds from any sale of shares by the Selling Stockholder. The Offering was upsized from the previously announced 2,500,000 shares based on strong investor demand. The Selling Stockholder has granted to the underwriters a 30-day option to purchase up to an additional 521,739 shares of Kinetik's Class A common stock. BofA Securities, J.P. Morgan and Morgan Stanley are acting as joint lead book-running managers for the Offering. Barclays, Citigroup, Credit Suisse, Goldman Sachs & Co. LLC, Mizuho Securities, RBC Capital Markets, TD Securities, Truist Securities and Wells Fargo Securities are acting as joint book-running managers for the Offering. Capital One Securities, MUFG and Scotiabank are acting as co-managers for the Offering.

07:33 EST CSI says both ISS and Glass Lewis support merger with Pineapple - Communications Systems provided investors with updated information related to the proposed merger transaction with Pineapple Energy . Updating on the current status of shareholder voting, Roger Lacey, CSI's Executive Chair and Interim CEO stated, "We are happy to announce that both ISS and Glass Lewis recently recommended unanimously that investors vote FOR the merger and each other proposal to be considered by shareholder. Currently, over 95% of current CSI shareholders who have already cast their vote have voted FOR the merger." "While we have experienced great support from CSI shareholders who have voted, I want to remind all CSI shareholders that not voting will have the same effect as a vote against the merger. Accordingly, it is extremely important that all CSI shareholders vote their shares," continued Mr. Lacey. "The CSI board of directors believes the merger is particularly attractive because CSI shareholders will have the opportunity to receive value from both the legacy CSI business and from the future Pineapple business in the growing residential solar market. We urge CSI shareholders to vote FOR the merger in order to ensure they can realize the value of their CSI shares and get the full benefit of this transformative transaction," concluded Mr. Lacey. As previously announced, the CSI board of directors unanimously recommends that its shareholders vote for the proposed Pineapple merger transaction. Following the completion of the proposed merger with Pineapple, CSI will be renamed "Pineapple Holdings will trade under the new Nasdaq ticker symbol "PEGY," and will be focused on the rapidly growing home solar, battery storage and energy management industry. Pineapple Holdings will initially operate primarily through its Pineapple, Hawaii Energy Connection and E-Gear subsidiary businesses and intends to pursue additional operating and technology acquisitions throughout 2022.

07:32 EST Protara Therapeutics expects cash to fund operations into mid-2024 - As of December 31, 2021, cash, cash equivalents and marketable debt securities totaled $130.7 million. The Company expects its cash, cash equivalents, and marketable debt securities will be sufficient to fund its planned operations into mid-2024.

07:31 EST Stella-Jones expects to return C$500M-C$600M to shareholders in 2022-2024 period - To better reflect its business dynamics, the Company is shifting its financial guidance to a three-year outlook. Over the next 3 years, Stella-Jones anticipates continued sales and EBITDA growth. It expects to generate an annual sales growth rate in the mid-single digit range from the 2019 pre-pandemic levels and continues to target EBITDA margin of approximately 15% for the 2022-2024 period. By core product categories for 2022-2024: The Company will expand its capital expenditure program and invest an additional $90 to $100 million to support the anticipated high single-digit organic growth in the utility poles category; The Company continues to project growth in the railway ties category in the low single-digits; and For residential lumber, the Company anticipates stable long-term demand but believes the market price of lumber will normalize. As a result, the Company expects its residential lumber sales to decrease compared to 2021 and assumes sales in the 2022-2024 period will be approximately 35% above the 2019 pre-pandemic levels. With the anticipated normalization of lumber prices and expected growth in the Company's infrastructure-related businesses, the sales of utility poles, railway ties and industrial product categories are expected to represent 75-80% of total sales, while the relative proportion of residential lumber sales is projected to stabilize to 20-25% by 2024. Based on its current business model, the Company projects returning to shareholders approximately $500 to $600 million in the 2022-2024 period. The Company plans to pursue acquisitions that further support growth in its infrastructure-related products categories. It also plans to evaluate growth opportunities in adjacent businesses where it can leverage its core knowledge and key attributes to generate continued strong cash flow. For strategic acquisitions, the Company anticipates increasing its leverage to finance such opportunities. As per its capital allocation strategy, the Company targets a leverage ratio of 2.0x-2.5x and may temporarily deviate and exceed its target to pursue acquisitions.

07:27 EST Nuvista Energy sees Q1 production 64,000-65,000 Boe/d - NuVista is pleased to note that operations and performance have been strong while both condensate and natural gas prices have increased significantly. This results in a material increase to projected adjusted funds flows and tremendous progress in reducing our net debt. NuVista's recent well performance has exceeded expectations, and in addition the on-stream dates for new wells have been ahead of schedule. As a result, first quarter production guidance is increased to 64,000 - 65,000 Boe/d as compared to the original guidance range of 60,000 - 62,000 Boe/d. Both of these ranges include condensate at approximately 32%, NGLs at 8%, and natural gas at 60%. Full year 2022 production guidance is unchanged at 65,000 - 68,000 Boe/d with a reminder that NuVista has some planned facility maintenance downtime in the second quarter. Capital expenditure guidance for 2022 is unchanged with a range of $290-310 million. We intend to continue our track record of carefully directing additional available adjusted funds flow towards a prudent balance of debt reduction and production growth until our existing facilities are filled to maximum efficiency. Capital expenditures will continue to be weighted towards Pipestone, as our highest return area, with expected well payouts well below a year. As previously communicated, 100% of free adjusted funds flow will continue to be directed towards the balance sheet until net debt reaches the interim milestone of $400 million. This is expected to be achieved during the second quarter of 2022. Free adjusted funds flow below the milestone is anticipated to be allocated between further debt reduction, the return of capital to shareholders through the buyback of shares, and possibly towards a moderate capital expenditure increase to optimize the operational continuity of our three-rig drilling program even further, if strip commodity prices remain strong. The specific nature of these free adjusted funds flow splits will be determined and communicated during the second quarter of 2022. Our board has approved a long term sustainable net debt target of less than 1.0 times adjusted funds flow in the stress test price environment of US$ 45/Bbl WTI and US$ 2.00/MMBtu NYMEX natural gas. In the context of our 2022 plan, this represents a target net debt level of $200 - $250 million. NuVista has an exceptional business plan that maximizes free adjusted funds flow and the return of capital to shareholders when our existing facilities are filled to capacity and maximum efficiency at production levels of approximately 85,000 - 90,000 Boe/d. We are confident that the actions described above accelerate the Company towards that goal by as early as 2023, while still providing free adjusted funds flow and net debt reduction concurrent with growing production through 2022-2023. With facilities optimized, returns are enhanced further with corporate netbacks which are expected to grow by approximately $2-$3/Boe due to the efficiencies of scale which will reduce our unit operating, transportation, and interest expenses by this amount.

07:23 EST Adaptive Biotechnologies appoints Peterson as CFO - Adaptive Biotechnologies (ADPT) announced the appointment of Tycho Peterson as chief financial officer, CFO. Peterson most recently held a 23-year tenure with J.P. Morgan Chase & Co (JPM), where he served as managing director, life science tools and diagnostics in the health care group.

07:20 EST StoneCo changes release date for Q4, FY21 results - StoneCo announces changes to release date of fourth quarter and fiscal year 2021 financial results to after market close on Thursday, March 17, 2022, instead of the previously announced date of March 10, 2022. The Company's conference call to discuss its fourth quarter and fiscal year 2021 financial results will be held on Thursday, March 17, 2022 at 5:00pm ET.

07:18 EST Medicenna Therapeutics announces poster presentations at AACR meeting - Medicenna Therapeutics announced the publication of two abstracts that have been accepted for electronic poster presentations at the American Association for Cancer Research Annual Meeting, which is taking place both virtually and in-person at the Ernest N. Morial Convention Center in New Orleans, Louisiana from April 8-13, 2022. Poster Title: An 'Anti-PD1-IL2 Beta-Only Super-Agonist' Displays Potent Anti-Tumor Efficacy: This poster will describe preclinical studies evaluating a therapeutic candidate derived from Medicenna's BiSKITs program. The evaluated bifunctional Superkine is designed to activate anti-cancer immune cells while limiting their exhaustion, and is composed of an anti-PD-1 antibody linked to an IL-2 Superkine exhibiting enhanced affinity for IL-2 receptor beta, and no binding to IL-2 receptor alpha. Poster Title: Characterization of a Long-Acting IL-13 Super-Antagonist Engineered to Target Tumor Associated Macrophages and Myeloid Cells: This poster will describe preclinical studies evaluating a long-acting IL-4/IL-13 super-antagonist that targets the IL-13 receptor alpha-1 component of type II IL-4 receptor expressed on tumor associated macrophages and myeloid derived suppressor cells. Inhibition of this receptor with the super-antagonist is intended to prevent tumor growth by promoting a pro-inflammatory tumor microenvironment.

07:12 EST Chatham Lodging buys Hilton Garden Inn Destin Miramar Beach, Fla for $31M - Chatham Lodging Trust announced that the company has acquired the beachside 111-room Hilton Garden Inn Destin Miramar Beach, Fla., in an off-market transaction for $31M, or approximately $279,000 per room. Recently opened in 2020, the hotel is within walking distance of the pristine white sands of the Gulf of Mexico. The hotel's location in Miramar Beach is well situated in relation to the thriving Santa Rosa Beach and Destin markets. The acquisition should generate an estimated stabilized NOI yield of 8.0% to 8.5%.

07:10 EST Thor Industries jumps 8% to $92.00 after Q2 results beat estimates

07:09 EST Marqeta selected by Citi to power mobile wallets offering - Marqeta (MQ) announced that Citi Commercial Cards (C) has selected its tokenization-as-a-service capabilities to facilitate the provisioning of cards into mobile wallets. Marqeta's tokenization functionality will integrate with Citi's existing systems and enable Citi's global cardholder base to provision corporate plastic cards as well as virtual cards into mobile wallets.

07:08 EST Oncorus expects cash to fund operations into late 2023 - Cash and cash equivalents and investments totaled $123.9 million as of December 31, 2021 compared to $130.3 million as of December 31, 2020. Based upon its current operating plans and cash and cash equivalents and investments, Oncorus expects to have sufficient capital to fund its operating expenses and capital expenditure requirements into late 2023.

07:06 EST TScan Therapeutics announces upcoming milestones - Upcoming Expected Milestones and Key Priorities for 2022. Liquid Tumor Programs: Initiate Phase 1 umbrella trial for TSC-100 following submission of clinical protocol to IRBs for the initial study sites, with plans to enroll patients in the first half of 2022. As previously disclosed, the FDA placed a clinical hold on the IND for TSC-101 in January 2022. Present initial clinical data from the liquid tumor program at a medical meeting in the second half of 2022. Solid Tumor Programs: Present initial preclinical data on the TSC-200 series at a medical meeting in the first half of 2022. Progress IND-enabling studies for the TSC-200 series and submit two IND applications during the second half of 2022. These are expected to include TSC-200 for HPV and TSC-204 for MAGE-A1. In 2023, the Company plans to release initial clinical data for the TSC-200 series TCRs, as well as file further INDs for additional programs in this series.

07:06 EST Lyra Therapeutics sees cash balance sufficient into Q4 - Reports Q4 net loss $13.6M vs. $7.0M a year ago. Cash and cash equivalents as of December 31, 2021 were $45.7M, compared with $58.1M as of September 30, 2021. The company expects its cash balance to be sufficient to fund its planned operations into 4Q 2022. "2021 was a highly productive year for Lyra as we advanced our clinical programs in our first indication - chronic rhinosinusitis, or CRS - with the first patient treated in the pivotal Phase 3 ENLIGHTEN program for LYR-210 in patients with surgically-naive anatomy and the initiation of the Phase 2 BEACON study for LYR-220 to treat CRS patients with post-surgical anatomy," said CEO Maria Palasis. "We expect 2022 to be a pivotal year as we enroll both late-stage clinical programs, report clinical data for Part 1 of the Phase 2 BEACON study around year end and present additional clinical data at the Combined Otolaryngology Spring Meetings that further distinguishes LYR-210 from current treatment options. With a portfolio of products to cover both surgically-naive and post-surgical CRS patients, Lyra is poised to excel in the estimated $6B target addressable market for CRS."

07:05 EST TScan Therapeutics expects cash to fund operations into 2024 - As of December 31, 2021, TScan Therapeutics had cash and cash equivalents of $161.4 million excluding $5.0 million of restricted cash. Based on current operating plans, the Company believes that existing cash and cash equivalents will be sufficient to fund its operating expenses and capital expenditure requirements into 2024.

07:03 EST Walmart's GoLocal and Delivery Solutions team on 'premium' delivery experience - Delivery Solutions, a provider of third-party aggregation and orchestration software for last-mile delivery and fulfillment, announced today that Walmart GoLocal, Walmart's white-label delivery as a service business, will join the Delivery Solutions platform as a last mile delivery service provider. The collaboration will further enable Delivery Solutions customers to deploy an omnichannel shopping experience complete with express, same-day and next-day delivery, providing retailers of all sizes with reliable, fast and efficient delivery. "We are very excited about this collaboration with Walmart GoLocal, as both our brands share a dedication to customer service and retail client support. As part of our ongoing commitment, we look forward to providing our customers with access to all options for same-day delivery," said Manil Uppal, founder of Delivery Solutions. "We are confident that Walmart GoLocal's capabilities, combined with our expertise in cutting-edge omnichannel programs, will provide Delivery Solutions customers with even more convenience and flexibility." Since its inception in 2018, Delivery Solutions has made a name for itself by offering an end-to-end white-label solution that includes everything from e-commerce delivery intelligence while the consumer is browsing, to post-purchase tracking, visibility, and communication. Because of advancements in mobility and online access, customers today expect a wide range of innovative, instantaneous delivery options that fit their post-pandemic lifestyles. As the inventor and leader of same-day delivery aggregation and orchestration, Delivery Solutions continues to delight brands and customers with innovative fulfillment, delivery, and post-purchase customer notifications, while also offering a competitive offering for traditional brick and mortar retail clients.

06:51 EST Express sees FY22 comparable sales up 7%-9% - Sees FY22 gross margin rate increasing approximately 100 basis points, SG&A expenses as a percent of sales approximately flat, including incremental investments in technology, higher labor expenses and general inflationary pressures, net interest expense of $13M, Capital expenditures of $50M-$55M, inventory elevated in the first half of the year and closer to parity with sales growth in the back half of the year.

06:50 EST Express sees Q1 comparable sales up 25%-30% year-over-year - Sees Q1 gross Margin rate increasing approximately 550 basis points, including approximately $7M of expenses related to mitigating supply chain challenges, SG&A expenses as a percent of sales to leverage approximately 250 basis points, net interest expense of $4M and effective Tax rate of approximately 50%.

06:48 EST Pfizer initiates Phase 2/3 study of PAXLOVID - Pfizer announced that it has initiated a Phase 2/3 study, EPIC-PEDS, to evaluate the safety, pharmacokinetics, and efficacy of Pfizer's PAXLOVID in non-hospitalized, symptomatic, pediatric participants with a confirmed diagnosis of COVID-19 who are at risk of progression to severe disease.

06:41 EST UniCredit warns of potential losses in 'extreme scenario' at Russia unit - UniCredit Bank Russia has a self-funded loan position at 2021 year end of EUR 7.8B, RWA of EUR 9.4B and equity of EUR 2.5B. Net of FX hedges, our direct exposure to UniCredit Bank Russia is reduced to around EUR 1.9B. Russian client cross border exposure is currently around EUR 4.5B, net of guarantees of around EUR 1B by non-Russian State Export Agencies, and accounts for around EUR 3B RWA. The exposure is almost entirely to leading Russian multinational corporations and mostly in EUR and USD currencies. The main sector exposures of the portfolio are around 30% to oil & gas, around 20% each to transport, and machinery & metals, around 10% to chemicals, around 8% to financial institutions and with the balance to a mix of other sectors. "We have a current mark-to-market derivative exposure to Russian banks of around EUR 300M, net of collateral received. The maximum potential loss in the event that the RUB would tend to zero is around EUR 1B. In the extreme scenario, where the entirety of our maximum exposure described above is non-recoverable and zeroed, the impact on UniCredit's 2021 year end CET1 ratio would be around 200bps. Our strong capital position would allow us to absorb such impact without falling below 13% CET. Whilst we do not consider this extreme scenario as our base case, we are taking a prudent and sustainable approach to our distributions," the company added. UniCredit confirmed its 2021 proposed cash dividend of EUR 1.2B, maintaining a 2021 CET1 ratio pro-forma above 13% even in the extreme scenario. Furthermore, the company confirms its intention to execute the share buyback up to the previously agreed amount of EUR 2.58B.

06:33 EST Wabtec introduces five-year financial targets, restructuring plans - Five-year value creation framework: Mid-single digits core organic growth CAGR; Adjusted operating margin expansion of 250 to 300 basis points; Double-digit adjusted EPS growth CAGR; Strong cash flow generation of greater than 90 percent conversion driving disciplined capital deployment. Wabtec announced the next phase of its restructuring plans designed to further consolidate, streamline, and simplify Wabtec's operations and systems. Wabtec expects expenses of $135M-$165M over the next three years to drive a targeted benefit savings of $75M-$90M.

06:02 EST Brunswick's Navico announces major capacity expansion of Mexico facility - Navico, a division of Brunswick's Advanced Systems Group, announced the planned expansion of its Ensenada, Mexico facility which will be completed over the next 16-18 months. The additional space will be used to increase vertical integration and production capacity to deliver the necessary volume growth to fulfil record demand for Navico's award-winning products. This marks Navico's first major expansion since joining Brunswick in October 2021 and it is expected to create more than 100 jobs in the Ensenada community. The investment will expand the current facility by 35% and include the construction of a new 50,500 sq. foot building with 47,200 sq. feet dedicated to additional production space. This is Brunswick's fifth major expansion announcement in the past year, in total, adding more than one million square feet of manufacturing footprint.

05:33 EST NRx Pharmaceuticals CEO Jonathan Javitt retires - NRx Pharmaceuticals announced that Jonathan Javitt has retired as CEO effective immediately. The board of directors appointed Robert Besthof, head of operations and chief commercial officer, as interim CEO. Besthof confirmed that given the changing global geopolitical environment the company will narrow its geographic focus on strategic priorities that are principally based in the United States. These are the development and approval of Zyesami, for treatment of Critical COVID-19 and other applications, and advancing the company's psychiatric portfolio, including NRX-101. The company will also continue to evaluate the global market, partnership, and development opportunities for the BriLife vaccine for the prevention of COVID-19.

05:28 EST Ram unveils 2023 Ram ProMaster, announces Amazon partnership for BEV in 2023 - Ram Commercial, part of Stellantis (STLA), revealed the new 2023 Ram ProMaster at the National Truck Equipment Association's, or NTEA, Work Truck Week trade show in Indianapolis, Indiana. The new 2023 Ram ProMaster is a full-size van designed for businesses, construction jobsites and commercial fleets. ProMaster includes features like cargo volume, turning radius, standard interior cargo height, load-floor height, cargo width between wheel wells and maximum cargo width. Ram ProMaster features up to 6,910 pounds of towing capability and a 4,680 pounds of payload. Ram Commercial will introduce a battery-electric ProMaster in 2023 in response to customer demand. More information will be available at a later date. Amazon (AMZN) will be the first commercial customer for Stellantis' new Ram ProMaster battery-electric vehicle, or BEV, launching in 2023. Stellantis, with input from Amazon, designed the vehicle with unique last-mile delivery features. Amazon will deploy the vehicles to routes across the United States. Building on the current relationship and as part of the long-term agreement, Stellantis and Amazon will be putting thousands of BEV ProMasters on the road every year.

05:16 EST Berkshire Grey, Tessiant announce automation partnership in the UK - Berkshire Grey and Tessiant, a change and transformation consultancy, announced their partnership to help transform supply chain operations through intelligent robotic automation of e-commerce fulfillment, store replenishment, package handling and logistics. Together, the two companies will give UK retailers access to the most advanced AI-enabled robotic solutions designed to meet consumer expectations for on-demand order fulfillment. With the launch of this partnership, UK companies will now have access to Berkshire Grey's extensive robotic solutions and services including design, installation, testing and commissioning, and continued support leveraging cloud-based AI solutions for predictive maintenance, management of system operations, analytics and integration.